Enantiomericallypure P-tolyl sulphinyl-N,N-dimethylthioacetamide (1) was prepared starting from (-)-(S)-menthyl toluene-p-sulphinate. Aldol-type condensation of (1) and subsequent removal of the Sulphinyl group open an entry to optically active β-hydroxy thioacetamides in 40–90% e.e.
CINQUINI, M.;MANFREDI, A.;MOLINARI, H.;RESTELLI, A., TETRAHEDRON, 1985, 41, N 21, 4929-4936
作者:CINQUINI, M.、MANFREDI, A.、MOLINARI, H.、RESTELLI, A.
DOI:——
日期:——
[EN] USE OF 1-PHENYL-3-DIMETHYLAMINOPROPANE COMPOUNDS FOR TREATING RHEUMATOID PAIN<br/>[FR] UTILISATION DE COMPOSÉS 1-PHÉNYL-3-DIMÉTHYLAMINOPROPANE POUR TRAITER UNE DOULEUR RHUMATOÏDE
申请人:GRUENENTHAL GMBH
公开号:WO2010124856A1
公开(公告)日:2010-11-04
The invention relates to the use of l-phenyl-3- dimethylaminopropane compounds for the production of medicaments for treating rheumatoid, preferably rheumatoid arthritic, very preferably chronic rheumatoid arthritic pain.